We are live on ! Find out more
RJFSA

Raymond James Financial Services Advisors Portfolio holdings

AUM $75.1B
1-Year Est. Return 31.89%
This Fund
S&P 500
This Quarter Est. Return
+6.19%
1 Year Est. Return
+31.89%
3 Year Est. Return
+38.17%
5 Year Est. Return
+106.56%
10 Year Est. Return
+236.84%
AUM
$56.7B
AUM Growth
+$3.9B
Cap. Flow
+$1.05B
Cap. Flow %
1.86%
Top 10 Hldgs %
16.65%
Holding
3,421
New
173
Increased
1,477
Reduced
1,449
Closed
187

Sector Composition

Rank Sector Weight
1 Technology 12.26%
2 Financials 6.2%
3 Healthcare 5.77%
4 Consumer Discretionary 5.02%
5 Industrials 4.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LILM
3151
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
$26.1K ﹤0.01%
+14,829
New +$13.8K
REFR icon
3152
Research Frontiers
REFR
$17.2M
$25.5K ﹤0.01%
15,935
CRIS icon
3153
Curis
CRIS
$4.83M
$25.5K ﹤0.01%
77
-3
-4% -$976
BBGI icon
3154
Beasley Broadcasting Group
BBGI
$40.3M
$25.2K ﹤0.01%
1,233
OESX icon
3155
Orion Energy Systems
OESX
$80.8M
$24.1K ﹤0.01%
1,480
BMRA icon
3156
Biomerica
BMRA
$4.85M
$23.8K ﹤0.01%
2,191
ZFOX
3157
DELISTED
ZeroFox Holdings, Inc. Common Stock
ZFOX
$22.7K ﹤0.01%
22,658
+2,194
+11% +$2.43K
HNST icon
3158
The Honest Company
HNST
$559M
$22.6K ﹤0.01%
13,450
-69
-0.5% -$118
NVTA
3159
DELISTED
Invitae Corporation
NVTA
$20.8K ﹤0.01%
18,428
+435
+2% +$549
UFAB
3160
DELISTED
Unique Fabricating, Inc.
UFAB
$20.6K ﹤0.01%
100,000
SPPI
3161
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$20K ﹤0.01%
20,812
+8,106
+64% +$8.01K
XOM icon
3162
PUT
ExxonMobil
XOM
$657B
$19K ﹤0.01%
200
VRAY
3163
DELISTED
ViewRay, Inc.
VRAY
$18.5K ﹤0.01%
52,570
-5,420
-9% -$5.62K
CRM icon
3164
CALL
Salesforce
CRM
$162B
$18.5K ﹤0.01%
100
DARE icon
3165
Dare Bioscience
DARE
$21.6M
$18.2K ﹤0.01%
1,668
+1
+0.1% +$12
XXII
3166
22nd Century Group
XXII
$1.52M
0
DXYN
3167
DELISTED
Dixie Group Inc
DXYN
$17.2K ﹤0.01%
12,900
-1,685
-12% -$1.62K
NGD
3168
DELISTED
New Gold Inc
NGD
$17K ﹤0.01%
15,739
SRGA
3169
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$16.8K ﹤0.01%
91,685
+80,000
+685% +$76.7K
RVLP
3170
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$16.5K ﹤0.01%
29,519
INTZ
3171
DELISTED
INTRUSION INC NEW
INTZ
$16.2K ﹤0.01%
13,249
PFIE
3172
DELISTED
Profire Energy, Inc
PFIE
$15.3K ﹤0.01%
12,408
LLAP
3173
DELISTED
Terran Orbital Corporation
LLAP
$15K ﹤0.01%
10,000
-30,487
-75% -$48.3K
URG
3174
Ur-Energy
URG
$553M
$14.7K ﹤0.01%
13,978
PYPD icon
3175
PolyPid
PYPD
$90.7M
$14.2K ﹤0.01%
1,296
-114
-8% -$1.37K

Similar funds

Raymond James Financial Services Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Raymond James Financial Services Advisors held 3,421 positions worth $56.7B, up 7.4% from $52.8B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Raymond James Financial Services Advisors's Q2 2023 filing shows 173 new, 1,477 increased, 1,449 reduced and 187 closed positions. Its largest new stake was Global X Emerging Markets Great Consumer ETF: 1,232,726 shares worth $30.7M. The largest sale was Vanguard Morningstar Growth ETF, an estimated $75.3M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James Financial Services Advisors's largest Q2 2023 buy was Global X Emerging Markets Great Consumer ETF: 1,232,726 shares worth $30.7M.
  • Raymond James Financial Services Advisors added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $135M increase.
  • Raymond James Financial Services Advisors's biggest Q2 2023 reduction was Vanguard Morningstar Growth ETF, cutting an estimated $75.3M.
  • Raymond James Financial Services Advisors fully exited SPDR S&P 600 Small Cap ETF (based on S&P SmallCap 600 Index--symbol SML) in Q2 2023, selling an estimated $5.34M.
  • Raymond James Financial Services Advisors's ten largest holdings make up 17% of its $56.7B portfolio in Q2 2023.
  • Raymond James Financial Services Advisors opened 173 new positions and closed 187 in Q2 2023.
  • Raymond James Financial Services Advisors's portfolio value rose 7.4% quarter-over-quarter to $56.7B.

Based on Raymond James Financial Services Advisors's 13F filing for Q2 2023, filed 25 Jul 2023.